Gerresheimer AG

Gerresheimer is a global manufacturer of pharmaceutical packaging and drug delivery systems based in Düsseldorf, Germany. The company specializes in primary packaging solutions made from specialized glass and plastics, including prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medications, along with closure and safety systems. Beyond pharmaceutical packaging, Gerresheimer produces drug delivery devices such as insulin pens, inhalers, and micropumps, as well as diagnostic and medical device solutions. The company also serves the cosmetics and personal care industries with high-quality packaging. With operations spanning over 40 production facilities across Europe, the Americas, and Asia, Gerresheimer operates close to its customers to ensure rapid solutions and sustainable production. Approximately 81% of the company's revenues derive from the pharmaceutical and healthcare sectors, while cosmetics and food and beverage products comprise the remainder. Founded in 1864, Gerresheimer went public in 2007 and remains committed to innovation, quality excellence, and sustainability, including targets for renewable energy procurement and carbon emission reductions by 2030.